Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:06 PM
Ignite Modification Date:
2025-12-24 @ 9:06 PM
NCT ID:
NCT03797404
Eligibility Criteria:
Inclusion criteria:
* adult \>18 years,
* severe uncontrolled asthma, defined as eosinophil blood count \>300/mm3 in the previous 12 months and at least 2 exacerbations in the previous 12 months or requiring oral steroids for more than half of the previous year,
* indication for mepolizumab decided by an asthma specialist,
* efficient contraception, for women of reproductive age
Exclusion criteria :
* pregnancy,
* smokers or ex smokers \>10 pack/yr,
* contra indication for fiberoptic bronchoscopy (allergy to xylocain, antiaggregant or anticoagulant treatment...),
* contra indication for mepolizumab,
* patient who previously received mepolizumab or already received mepolizumab at inclusion,
* participation in another interventional trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03797404
Study Brief:
Protocol Section:
NCT03797404